Serial Number
75644415
Owner
PAREXEL INTERNATIONAL CORPORATIONAttorney
Douglas R. WolfFirst Use Date
Jan 1, 1983
Filing Date
Feb 5, 1999
PAREXEL Trademark
Serial Number: 75644415 • Registration: 2407845
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
February 5, 1999
Registration Date
November 28, 2000
First Use Anywhere
January 1, 1983
First Use in Commerce
January 1, 1983
Published for Opposition
September 5, 2000
Goods & Services
MARKET RESEARCH IN THE FIELD OF INTERNATIONAL HEALTH, THE PHARMACEUTICAL INDUSTRY, THE BIOTECHNOLOGY INDUSTRY AND THE MEDICAL DEVICE AND DIAGNOSTICS INDUSTRIES; BUSINESS MARKETING CONSULTING SERVICES IN THE FIELD OF INTERNATIONAL HEALTH, THE PHARMACEUTICAL INDUSTRY, THE BIOTECHNOLOGY INDUSTRY AND THE MEDICAL DEVICE AND DIAGNOSTICS INDUSTRIES; MARKET ANALYSIS; PROVIDING BUSINESS INFORMATION, NAMELY, INFORMATION USEFUL FOR THE INTRODUCTION OF NEW PRODUCTS IN THE FIELD OF INTERNATIONAL HEALTH, THE PHARMACEUTICAL INDUSTRY, THE BIOTECHNOLOGY INDUSTRY AND THE MEDICAL DEVICE AND DIAGNOSTICS INDUSTRIES; PROVIDING STATISTICAL INFORMATION IN THE FIELD OF INTERNATIONAL HEALTH, THE PHARMACEUTICAL INDUSTRY, THE BIOTECHNOLOGY INDUSTRY AND THE MEDICAL DEVICE AND DIAGNOSTICS INDUSTRIES; AND DATA PROCESSING SERVICES IN THE FIELD OF INTERNATIONAL HEALTH, THE PHARMACEUTICAL INDUSTRY, THE BIOTECHNOLOGY INDUSTRY AND THE MEDICAL DEVICE AND DIAGNOSTICS INDUSTRIES
CONSULTING SERVICES IN THE FIELD OF CONDUCTING CLINICAL TRIALS, REGULATORY AFFAIRS, DRUG DEVELOPMENT, MANUFACTURING COMPLIANCE AND VALIDATION, ADVANCED TECHNOLOGY, CLINICAL BENCHMARKING AND PERFORMANCE IMPROVEMENT USED IN CONNECTION WITH THE TRAINING OF PROFESSIONALS IN THE FIELD OF INTERNATIONAL HEALTH, THE PHARMACEUTICAL INDUSTRY, THE BIOTECHNOLOGY INDUSTRY AND THE MEDICAL DEVICE AND DIAGNOSTICS INDUSTRIES; AND CONSULTATION IN THE FIELD OF PUBLISHING RELATING TO CONDUCTING CLINICAL TRIALS, REGULATORY AFFAIRS, DRUG DEVELOPMENT, MANUFACTURING COMPLIANCE AND VALIDATION, ADVANCED TECHNOLOGY, CLINICAL BENCHMARKING AND PERFORMANCE IMPROVEMENT IN THE FIELD OF INTERNATIONAL HEALTH, THE PHARMACEUTICAL INDUSTRY, THE BIOTECHNOLOGY INDUSTRY AND THE MEDICAL DEVICE AND DIAGNOSTICS INDUSTRIES